Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
recombinant factor VIII |
| gptkbp:activeIngredient |
efmoroctocog alfa
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:FDA
2014 treatment of bleeding episodes perioperative management prophylaxis of bleeding |
| gptkbp:ATCCode |
B02BD02
|
| gptkbp:form |
powder for solution for injection
|
| gptkbp:halfLife |
prolonged
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eloctate
|
| gptkbp:indication |
congenital factor VIII deficiency
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
replaces missing or deficient factor VIII
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
gptkb:hemophilia_A
|
| gptkbp:bfsParent |
gptkb:Bioverativ
|
| gptkbp:bfsLayer |
7
|